Print ISSN: 2393-9079
Online ISSN: 2393-9087
CODEN : IJPPTK
Indian Journal of Pharmacy and Pharmacology (IJPP) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award programs. With more...Review Article
Author Details :
Volume : 9, Issue : 3, Year : 2022
Article Page : 143-149
https://doi.org/10.18231/j.ijpp.2022.026
Abstract
Corona virus (COVs) are RNA virus that comes from the family COVs are pathogenic to animals as well as human beings and can cause ailment related to respiratory system such as severe acute respiratory syndrome (SARS) and COVID-19. However treatment of COVID-19 is one of the major area of concern as there are no appropriate treatment options available, however few herbal products are being used to boost the immunity of patients and in turn prevent the occurrence of infection. Historically India has always been rich with plants and is known to use herbs and plants in traditional system of healing. India has distinct traditional system of medicine called AYUSH that represents Ayurveda, Yoga, Unani, Siddha and homeopathy. This traditional system of medicine can be used to fight against COVID-19 pandemic. Present study describes about different herbs and plants of Indian origin that can be used for effective management COVID-19 and in future that can act as potential candidate for development of improved drugs for therapy of COVID-19 infection.
Keywords: Herbs, Corona virus, SARS, Pandemic, AYUSH
How to cite : Satapathy A, Satapathy T, Sahu H, Mishra S P, Dutta S, Therapeutic potential and pharmacological properties of Indian herbs for the management of SARS-COV-2 coronavirus disease: A research based review. Indian J Pharm Pharmacol 2022;9(3):143-149
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.